Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma

Bibliographic Details
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2023-07-01
Series:	Blood Science
Online Access:	http://journals.lww.com/10.1097/BS9.0000000000000164

Similar Items

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
by: Ru Li, et al.
Published: (2023-04-01)

Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies
by: Vibor Milunović, et al.
Published: (2017-01-01)

Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma
by: Aguiar-Bujanda D, et al.
Published: (2015-10-01)

Follicular lymphoma
by: Ellen Leich, (Coordinating Author)
Published: (2019-06-01)

Follicular Lymphoma
by: İrfan Yavaşoğlu
Published: (2015-02-01)

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP
by: Vít Procházka, et al.
Published: (2020-07-01)

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma
by: Klaus Herfarth, et al.
Published: (2018-12-01)

Clinical and biological prognostic factors in follicular lymphoma patients.
by: Ádám Jóna, et al.
Published: (2022-01-01)

Clinical and biological prognostic factors in follicular lymphoma patients
by: Ádám Jóna, et al.
Published: (2022-01-01)

Follicular lymphoma genomics
by: Emil Kumar, et al.
Published: (2019-06-01)

Controversies in the Treatment of Follicular Lymphoma
by: Kai Hübel, et al.
Published: (2020-02-01)

Blastic transformation of follicular lymphoma
by: Hayato Mori, et al.
Published: (2024-02-01)

Targeted Treatment of Follicular Lymphoma
by: Karthik Nath, et al.
Published: (2021-02-01)

Genetics of Transformed Follicular Lymphoma
by: Miguel Alcoceba, et al.
Published: (2022-10-01)

Duodenal-Type Follicular Lymphoma
by: Afra Abdulla Juma, et al.
Published: (2023-01-01)

Diagnosis and treatment of follicular lymphoma
by: F Hitz, et al.
Published: (2011-08-01)

Renal Infiltration of Follicular Lymphoma
by: Ivan Petkovic, et al.
Published: (2014-08-01)

Pediatric-type follicular lymphoma
by: Anuj Verma, et al.
Published: (2022-03-01)

PB2070: EFFICACY OF RITUXIMAB MAINTENANCE THERAPY IN ADVANCED-STAGE FOLLICULAR LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY.
by: C. Amorós, et al.
Published: (2022-06-01)

Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance
by: Carole Durot, et al.
Published: (2023-06-01)

Novel prognostic tools that identify high-risk follicular lymphoma
by: Stefano Luminari
Published: (2019-06-01)

Prostate Involvement in a Patient with Follicular Lymphoma
by: Seda Yılmaz, et al.
Published: (2017-11-01)

Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale
by: Jan Dürig, et al.
Published: (2023-02-01)

BNIP3 expression in follicular lymphoma.
by: Sington, J, et al.
Published: (2007)

Treatment of high-risk follicular lymphoma
by: Wojciech Jurczak
Published: (2019-06-01)

CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01)

Primary cutaneous T‐follicular helper lymphoma
by: Elena M. Fenu, et al.
Published: (2023-11-01)

Diagnosis and treatment of follicular lymphoma: an update
by: Mario Bargetzi, et al.
Published: (2018-07-01)

Managing Follicular Lymphoma in the Elderly Population
by: Jiao Jie Cherie Tan, et al.
Published: (2023-01-01)

Large B-cell lymphoma with IRF4 rearrangement and follicular Pattern: A differential diagnosis of follicular lymphoma
by: Do Hwan Kim, et al.
Published: (2022-03-01)

CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
by: Razan Mohty, et al.
Published: (2022-12-01)

P1215: CHARACTERIZATION AND CLINICAL SIGNIFICANCE OF T FOLLICULAR HELPER SUBSETS IN FOLLICULAR LYMPHOMA
by: Zhi-Zhang Yang, et al.
Published: (2023-08-01)

The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China
by: Jingjing Ge, et al.
Published: (2022-10-01)

Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma
by: Loretta J. Nastoupil, et al.
Published: (2022-05-01)

Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab
by: Akie Hirata, et al.
Published: (2022-12-01)

Comparison of Follicular Helper T-Cell Markers with the Expression of the Follicular Homing Marker CXCR5 in Peripheral T-Cell Lymphomas—A Reappraisal of Follicular Helper T-Cell Lymphomas
by: László Krenács, et al.
Published: (2023-12-01)

Treatment selection for patients with relapsed or refractory follicular lymphoma
by: Alan Z. Skarbnik, et al.
Published: (2023-03-01)

A rare case of follicular lymphoma of the bladder
by: Matthew DeSanto, et al.
Published: (2023-11-01)

Skin lesions as the first manifestation of follicular lymphoma
by: Julia Nowowiejska, et al.
Published: (2023-11-01)

Tumor Microenvironment and Microvascular Density in Follicular Lymphoma
by: Roberto Tamma, et al.
Published: (2022-02-01)